Hot therapy for cold agglutinin disease
- PMID: 28751358
- DOI: 10.1182/blood-2017-06-788463
Hot therapy for cold agglutinin disease
Conflict of interest statement
Conflict-of-interest disclosure: U.J. has received honoraria from Roche and True North Therapeutics.
Comment on
-
Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial.Blood. 2017 Jul 27;130(4):537-541. doi: 10.1182/blood-2017-04-778175. Epub 2017 May 22. Blood. 2017. PMID: 28533306 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources